David Porter

Company: Penn Medicine/ University of Pennsylvania

Job title: Director - Cell Therapy & Transplant

Seminars:

Panel Discussion: Optimizing Patient Treatment Procedure for Best Outcomes

Moderator: Greg Deener, Chief Executive Officer, iCell Gene Therapeutics 2:00 pm

• Discussing regiments for patients such as ideal dosing, timing of certain procedures, and sample collection methods • Evaluating the need for conditioning regiments such as lymphodepletion • How long do patients need to be hospitalized?Read more

day: Day Two Track B, PM

Workshop B 1:00 pm

With many developers rapidly moving into clinics with candidates that have demonstrated outstanding preclinical results the community now faces challenges in maximizing clinical outcomes when facing competition for clinical resources with the oncology field and a lack of awareness of cell therapies in the autoimmune space. Join this workshop to: Discuss strategies to unite autoimmune…Read more

day: Pre-Conference Workshop Day